Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Jared E. Knickelbein"'
Publikováno v:
Ophthalmology and Eye Diseases, Vol 2009, Iss 1, Pp 45-54 (2009)
The composition and location of professional antigen presenting cells (APC) varies in different mucosal surfaces. The cornea, long considered an immune-privileged tissue devoid of APCs, is now known to host a heterogeneous network of bone marrow-deri
Externí odkaz:
https://doaj.org/article/38de0c01c4914351aefafd49dee179e2
Autor:
Luis A. Gonzalez-Gonzalez, Jared E. Knickelbein, Bernard H. Doft, G. K. Balasubramani, Stephen Wisniewski
Publikováno v:
International Ophthalmology. 43:867-876
Autor:
Luz Elena Concha-Del-Río, Victor Velasquez, Lourdes Arellanes-Garcia, Rodrigo Anguita, Loreto Cuitino, Jared E. Knickelbein, Sergio Morales, H. Nida Sen, Cristhian A. Urzua, Uriel Moreno, Francisco A Villarroel
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 259:2905-2911
Due to the guarded prognosis of acute retinal necrosis (ARN), it is relevant to develop a strategy to early categorize those patients in a higher risk of worse outcomes. The purpose of this study is to describe clinical features and predictive factor
Autor:
Maggie M Wei, Jared E. Knickelbein, H. Nida Sen, Chi-Chao Chan, Ian Y L Yeung, Karen R Armbrust, David Kuo, Aaron Y. Lee
Publikováno v:
Ophthalmology. 127:956-962
Purpose To assess the diagnostic performance and generalizability of logistic regression in classifying primary vitreoretinal lymphoma (PVRL) versus uveitis from intraocular cytokine levels in a single-center retrospective cohort, comparing a logisti
Autor:
Luis A, Gonzalez-Gonzalez, Jared E, Knickelbein, Bernard H, Doft, G K, Balasubramani, Stephen, Wisniewski
Publikováno v:
International ophthalmology.
To describe the incidence and factors predicting visual outcome in patients with infectious endophthalmitis following intravitreal anti-VEGF injection.Retrospective, single-site, cohort study. Patients with acute endophthalmitis within 6 weeks of int
Autor:
Maggie M Wei, Jared E. Knickelbein, Shuk Kei Cheng, Natasha Kesav, Brett G. Jeffrey, Susan Vitale, H. Nida Sen
Publikováno v:
Ocul Immunol Inflamm
Purpose: Aims to determine the variability of ffERG measurements in patients with clinically stable birdshot chorioretinopathy (BCR). Methods: Repeatability coefficients (RC) of ffERG amplitudes and implicit times were calculated from 11 BCR patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1faea0d410d0c945142b7a2dd1622f
Autor:
Jared E. Knickelbein, Maggie M Wei, H. N. Sen, Ian Y L Yeung, Robert B. Nussenblatt, Chi-Chao Chan, Karen R Armbrust, David Kuo
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 33:319-324
To investigate the effectiveness of gradient boosting to classify endophthalmitis versus uveitis and lymphoma by intraocular cytokine levels.Patient diagnoses and aqueous and vitreous levels of interleukin (IL)-6 and IL-10 were retrospectively extrac
Autor:
Wai T. Wong, Catherine A Cukras, Catherine B. Meyerle, Naima Jacobs-El, Henry E. Wiley, Jared E. Knickelbein, Emily Y. Chew
Publikováno v:
Ophthalmology Retina. 1:181-187
Purpose To describe the clinical course of advanced juxtapapillary retinal capillary hemangioblastomas (RCHs) associated with von Hippel-Lindau (VHL) disease treated with systemic sunitinib malate, an agent that inhibits both anti–vascular endothel
Publikováno v:
Expert Review of Ophthalmology. 12:313-319
INTRODUCTION: Non-infectious uveitis encompasses a group of inflammatory eye diseases that can cause irreversible vision loss if left untreated or undertreated. In cases requiring stemic treatment, a step-wise treatment approach is often employed sta
Autor:
Karen R Armbrust, Jared E. Knickelbein, David Valent, Robert B. Nussenblatt, William R Tucker, H. Nida Sen, Nirali Bhatt, Dominic Obiyor
Publikováno v:
American Journal of Ophthalmology. 172:104-110
Purpose To evaluate the safety and potential efficacy of gevokizumab, an anti-interleukin 1β (IL-1β) monoclonal antibody, in the treatment of active, noninfectious, non-necrotizing anterior scleritis. Design Phase 1/2, open label, nonrandomized, pr